Almirall prints debut €250m convertible bond

Almirall, the Spanish pharmaceuticals company, has issued its first convertible bond with an equity-neutral structure, having attracted “strong outright demand” from institutional investors, according to a banker on the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: